Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acurx Pharmaceuticals Inc (ACXP)

Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,062
  • Shares Outstanding, K 22,398
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,100 K
  • EBIT $ -14 M
  • EBITDA $ -14 M
  • 60-Month Beta -1.36
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.27
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.87
  • Most Recent Earnings $-0.16 on 03/17/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 714.04% ( +323.40%)
  • Historical Volatility 74.79%
  • IV Percentile 97%
  • IV Rank 75.48%
  • IV High 943.93% on 12/19/24
  • IV Low 6.51% on 10/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 611
  • Open Int (30-Day) 944

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3000 +34.87%
on 04/09/25
0.4400 -8.05%
on 03/26/25
-0.0209 (-4.91%)
since 03/25/25
3-Month
0.3000 +34.87%
on 04/09/25
0.8699 -53.49%
on 01/27/25
-0.4670 (-53.58%)
since 01/24/25
52-Week
0.3000 +34.87%
on 04/09/25
3.3250 -87.83%
on 07/18/24
-1.6154 (-79.97%)
since 04/25/24

Most Recent Stories

More News
New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 16, 2025 / New to The Street, a premier business television and media platform, is proud to announce the renewal of its media partnership with Acurx Pharmaceuticals,...

ACXP : 0.4046 (+0.72%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice

New to The Street debuts its inaugural restaurant segment featuring BlackBarn with owner and chef John Doherty

RDZN : 0.9110 (+3.17%)
HIT : 0.6641 (+0.62%)
PETV : 0.5445 (+4.73%)
ACXP : 0.4046 (+0.72%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President

BlackBarn Restaurant NYC on 26th street The premiere restaurant segment with Owner and Head Chef John Doherty

RDZN : 0.9110 (+3.17%)
HIT : 0.6641 (+0.62%)
PETV : 0.5445 (+4.73%)
ACXP : 0.4046 (+0.72%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice

New Segment "Market Bites" Debuts with Chef John Doherty of BlackBarn Showcasing the Culinary Side of Business Leadership

RDZN : 0.9110 (+3.17%)
PETV : 0.5445 (+4.73%)
ACXP : 0.4046 (+0.72%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street & Sight & Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP

NEW YORK CITY, NEW YORK / ACCESS Newswire / March 14, 2025 / The highly anticipated Visionaries Series from New to The Street and Sight & Sound premieres tomorrow on Bloomberg at 6:30 PM EST as sponsored...

PLXP : 0.0207 (unch)
DPRX : 1.34 (+3.08%)
ACXP : 0.4046 (+0.72%)
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ) to other anti-CDI antibiotics in a germ-free mouse model...

ACXP : 0.4046 (+0.72%)
Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI

Major finding provides mechanistic explanation for ibezapolstat's (IBZ) selectivity in that the predicted bactericidal interaction between IBZ and its target...

ACXP : 0.4046 (+0.72%)
New to the Street to Broadcast Show 627 on Bloomberg Television at 6:30 PM EST Today as Sponsored Programming

Featured Segments Include Kevin Harrington on The Sustainable Green Team, Atlas Clear, High Performance Battery, and Modular Medical

ACXP : 0.4046 (+0.72%)
MODD : 0.9300 (-0.64%)
SGTM : 0.0754 (+0.53%)
Pro-Crypto Administration Sparks Wave of Bitcoin Investments from Various Sectors

Issued on behalf of Spearmint Resources Inc. VANCOUVER – USA News Group – As the inauguration of U.S....

BLK : 907.69 (-0.94%)
PYPL : 65.34 (+0.88%)
ACXP : 0.4046 (+0.72%)
^XRPBTC : 0.0000233 (+0.87%)
SMLR : 36.84 (+6.97%)
^XRPUSDT : 2.196246 (+0.12%)
^XRPUSD : 2.200256 (-0.04%)
SPMTF : 0.0108 (+4.85%)
SPMT.CN : 0.0200 (+33.33%)
^BTCUSDT : 94,073.91 (-0.80%)
^BTCUSD : 94,224.60 (-0.77%)
Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

STATEN ISLAND, NY / ACCESSWIRE / December 11, 2024 / Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company") (NASDAQ:ACXP), a late-stage biopharmaceutical company developing a new class of small molecule...

ACXP : 0.4046 (+0.72%)

Business Summary

Acurx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It focused on developing new antibiotics to treat infections. Acurx Pharmaceuticals Inc. is based in STATEN ISLAND, N.Y.

See More

Key Turning Points

3rd Resistance Point 0.4197
2nd Resistance Point 0.4149
1st Resistance Point 0.4097
Last Price 0.4046
1st Support Level 0.3997
2nd Support Level 0.3949
3rd Support Level 0.3897

See More

52-Week High 3.3250
Fibonacci 61.8% 2.1695
Fibonacci 50% 1.8125
Fibonacci 38.2% 1.4555
Last Price 0.4046
52-Week Low 0.3000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar